If the white blood cells are still low after taking a leukocyte boosting injection, if the patient is undergoing chemotherapy, he needs to stop chemotherapy, and if the patient is not undergoing chemotherapy, he needs to take into account the reasonableness of the treatment of the primary disease.
The main ingredient of leukapheresis injection is recombinant human granulocyte stimulating factor, which can stimulate bone marrow hematopoiesis to produce white blood cells after entering the human body, and the lack of effect after leukapheresis injection is most common in patients undergoing chemotherapy, mainly due to bone marrow suppression caused by chemotherapeutic drugs, and in this case, chemotherapy needs to be suspended.
Non-chemotherapy patients consider whether the primary disease treatment is enough course of treatment, the primary disease is poorly controlled by the bone marrow is severely inhibited, and whether the drug dose is up to standard.
It is recommended to go to the regular hospital for consultation and examination, to clarify the cause of the disease and then targeted treatment, do not use drugs privately to avoid causing adverse effects.